Kaspi.kz Vyacheslav Kim sells 100,431 depositary shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Joint Stock Co Kaspi.kz (KSPI) director Vyacheslav Kim reported direct sales of 100,431 American Depositary Shares across November 9, 10 and 11, 2026. Each ADS represents one common share. The sales were reported under a Rule 10b5-1 plan.
Transaction entries show weighted-average prices per ADS. On November 9, Kim sold 37,730 at $89.75, 5,164 at $90.45 and 427 at $91.29. On November 10, he sold 20,745 at $87.40, 8,886 at $88.17, 11,417 at $89.25 and 190 at $89.88. On November 11, he sold 2,364 at $88.68, 11,649 at $89.57 and 1,859 at $90.37.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | American Depositary Shares, no par value F1, F8 | 2,364 | $88.68 | $210K |
| Sale | American Depositary Shares, no par value F1, F9 | 11,649 | $89.57 | $1.04M |
| Sale | American Depositary Shares, no par value F1, F10 | 1,859 | $90.37 | $168K |
| Sale | American Depositary Shares, no par value F1, F5 | 20,745 | $87.40 | $1.81M |
| Sale | American Depositary Shares, no par value F1, F6 | 8,886 | $88.17 | $783K |
| Sale | American Depositary Shares, no par value F1, F7 | 11,417 | $89.25 | $1.02M |
| Sale | American Depositary Shares, no par value F1 | 190 | $89.88 | $17K |
| Sale | American Depositary Shares, no par value F1, F2 | 37,730 | $89.75 | $3.39M |
| Sale | American Depositary Shares, no par value F1, F3 | 5,164 | $90.45 | $467K |
| Sale | American Depositary Shares, no par value F1, F4 | 427 | $91.29 | $39K |
Footnotes (10)
- F1. Each American Depositary Share (ADS) represents one common share of the issuer.
- F2. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $89.15 to $90.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $90.165 to $91.055, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $91.195 to $91.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $86.82 to $87.805, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $87.845 to $88.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $88.85 to $89.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $88.19 to $89.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $89.225 to $90.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The price reported in Column 8 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $90.235 to $90.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many KSPI ADSs did director Vyacheslav Kim sell?
What weighted-average prices were reported for Vyacheslav Kim’s KSPI sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.